The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2

Virology

Volumn 367, Issue 2, 2007, Pages 367-374

  Li, Wenhui ^a   Sui, Jianhua ^b   Huang, I Chueh ^a   Kuhn, Jens H ^a,c   Radoshitzky, Sheli R ^a   Marasco, Wayne A ^b   Choe, Hyeryun ^a   Farzan, Michael ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Angiotensin converting enzyme 2; Human coronavirus NL63; SARS coronavirus; Viral entry

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; VIRUS RECEPTOR; VITRONECTIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; CORONAVIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SARS CORONAVIRUS; VIRUS STRAIN;

BINDING SITES; CELL LINE; CORONAVIRUS 229E, HUMAN; CORONAVIRUS INFECTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, CELL SURFACE; SARS VIRUS; VIRAL ENVELOPE PROTEINS;

CORONAVIRUS; SARS CORONAVIRUS;

EID: 34848819694     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.04.035     Document Type: Article

References (47)

1. Arden K.E., Nissen M.D., Sloots T.P., and Mackay I.M. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J. Med. Virol. 75 3 (2005) 455-462
2. Bastien N., Anderson K., Hart L., Van Caeseele P., Brandt K., Milley D., Hatchette T., Weiss E.C., and Li Y. Human coronavirus NL63 infection in Canada. J. Infect. Dis. 191 4 (2005) 503-506 (electronic publication 2005 Jan 4)
3. Bonavia A., Zelus B.D., Wentworth D.E., Talbot P.J., and Holmes K.V. Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J. Virol. 77 4 (2003) 2530-2538
4. Bosch B.J., van der Zee R., de Haan C.A., and Rottier P.J. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77 16 (2003) 8801-8811
5. Breslin J.J., Mork I., Smith M.K., Vogel L.K., Hemmila E.M., Bonavia A., Talbot P.J., Sjostrom H., Noren O., and Holmes K.V. Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37 degrees C. J. Virol. 77 7 (2003) 4435-4438
6. Chiu S.S., Chan K.H., Chu K.W., Kwan S.W., Guan Y., Poon L.L., and Peiris J.S. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin. Infect. Dis. 40 12 (2005) 1721-1729 (electronic publication 2005 May 10)
7. Colman P.M., and Lawrence M.C. The structural biology of type I viral membrane fusion. Nat. Rev., Mol. Cell Biol. 4 4 (2003) 309-319
8. Dveksler G.S., Pensiero M.N., Cardellichio C.B., Williams R.K., Jiang G.S., Holmes K.V., and Dieffenbach C.W. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65 12 (1991) 6881-6891
9. Dveksler G.S., Dieffenbach C.W., Cardellichio C.B., McCuaig K., Pensiero M.N., Jiang G.S., Beauchemin N., and Holmes K.V. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67 1 (1993) 1-8
10. Ebihara T., Endo R., Ma X., Ishiguro N., and Kikuta H. Detection of human coronavirus NL63 in young children with bronchiolitis. J. Med. Virol. 75 3 (2005) 463-465
11. Esper F., Weibel C., Ferguson D., Landry M.L., and Kahn J.S. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J. Infect. Dis. 191 4 (2005) 492-498 (electronic publication 2005 Jan 14)
12. Fouchier R.A., Hartwig N.G., Bestebroer T.M., Niemeyer B., de Jong J.C., Simon J.H., and Osterhaus A.D. A previously undescribed coronavirus associated with respiratory disease in humans. Proc. Natl. Acad. Sci. U. S. A. 101 16 (2004) 6212-6216 (electronic publication 2004 Apr 8)
13. Gallagher T.M., and Buchmeier M.J. Coronavirus spike proteins in viral entry and pathogenesis. Virology 279 2 (2001) 371-374
14. Gerna G., Campanini G., Rovida F., Percivalle E., Sarasini A., Marchi A., and Baldanti F. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J. Med. Virol. 78 7 (2006) 938-949
15. Hofmann H., and Pohlmann S. Cellular entry of the SARS coronavirus. Trends Microbiol. 12 10 (2004) 466-472
16. Hofmann H., Pyrc K., van der Hoek L., Geier M., Berkhout B., and Pohlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl. Acad. Sci. U. S. A. 16 (2005) 16
17. Hofmann H., Simmons G., Rennekamp A.J., Chaipan C., Gramberg T., Heck E., Geier M., Wegele A., Marzi A., Bates P., and Pohlmann S. Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J. Virol. 80 17 (2006) 8639-8652
18. Holmes K.V., Dveksler G., Gagneten S., Yeager C., Lin S.H., Beauchemin N., Look A.T., Ashmun R., and Dieffenbach C. Coronavirus receptor specificity. Adv. Exp. Med. Biol. 342 (1993) 261-266
19. Huang I.C., Bosch B.J., Li F., Li W., Lee K.H., Ghiran S., Vasilieva N., Dermody T.S., Harrison S.C., Dormitzer P.R., Farzan M., Rottier P.J., and Choe H. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem. 281 6 (2006) 3198-3203
20. Jackwood M.W., Hilt D.A., Callison S.A., Lee C.W., Plaza H., and Wade E. Spike glycoprotein cleavage recognition site analysis of infectious bronchitis virus. Avian Dis. 45 2 (2001) 366-372
21. Kaiser L., Regamey N., Roiha H., Deffernez C., and Frey U. Human coronavirus NL63 associated with lower respiratory tract symptoms in early life. Pediatr. Infect. Dis. J. 24 11 (2005) 1015-1017
22. Kubo H., Yamada Y.K., and Taguchi F. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 68 9 (1994) 5403-5410
23. Lau S.K., Woo P.C., Li K.S., Huang Y., Tsoi H.W., Wong B.H., Wong S.S., Leung S.Y., Chan K.H., and Yuen K.Y. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. U. S. A. 102 39 (2005) 14040-14045
24. Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M., Ahuja A., Yung M.Y., Leung C.B., To K.F., Lui S.F., Szeto C.C., Chung S., and Sung J.J. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348 20 (2003) 1986-1994
25. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzeriaga C., Greenough T.C., Choe H., and Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003) 450-454
26. Li W., Greenough T.C., Moore M.J., Vasilieva N., Somasundaran M., Sullivan J.L., Farzan M., and Choe H. Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine Angiotensin-converting enzyme 2. J. Virol. 78 20 (2004) 11429-11433
27. Li F., Li W., Farzan M., and Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309 5742 (2005) 1864-1868
28. Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H., Wang H., Crameri G., Hu Z., Zhang H., Zhang J., McEachern J., Field H., Daszak P., Eaton B.T., Zhang S., and Wang L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science 310 5748 (2005) 676-679
29. Li W., Zhang C., Sui J., Kuhn J.H., Moore M.J., Luo S., Wong S.K., Huang I.C., Xu K., Vasilieva N., Murakami A., He Y., Marasco W.A., Guan Y., Choe H., and Farzan M. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 24 (2005) 24
30. Li W., Wong S.K., Li F., Kuhn J.H., Huang I.C., Choe H., and Farzan M. Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J. Virol. 80 9 (2006) 4211-4219
31. McIntosh K. Coronaviruses in the limelight. J. Infect. Dis. 191 4 (2005) 489-491 (electronic publication 2005 Jan 14)
32. Moore M.J., Dorfman T., Li W., Wong S.K., Li Y., Kuhn J.H., Coderre J., Vasilieva N., Han Z., Greenough T.C., Farzan M., and Choe H. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. J. Virol. 78 19 (2004) 10628-10635
33. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., Cheng V.C., Chan K.H., Tsang D.N., Yung R.W., Ng T.K., and Yuen K.Y. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 9366 (2003) 1319-1325
34. Pyrc K., Jebbink M.F., Berkhout B., and van der Hoek L. Genome structure and transcriptional regulation of human coronavirus NL63. Virol. J. 1 1 (2004) 7
35. Smith M.K., Tusell S., Travanty E.A., Berkhout B., van der Hoek L., and Holmes K.V. Human angiotensin-converting enzyme 2 (ACE2) is a receptor for human respiratory coronavirus NL63. Adv. Exp. Med. Biol. 581 (2006) 285-288
36. Sturman L.S., and Holmes K.V. Proteolytic cleavage of peplomeric glycoprotein E2 of MHV yields two 90K subunits and activates cell fusion. Adv. Exp. Med. Biol. 173 (1984) 25-35
37. Sturman L.S., Ricard C.S., and Holmes K.V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56 3 (1985) 904-911
38. Sui J., Li W., Roberts A., Matthews L.J., Murakami A., Vogel L., Wong S.K., Subbarao K., Farzan M., and Marasco W.A. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J. Virol. 79 10 (2005) 5900-5906
39. Vabret A., Mourez T., Dina J., van der Hoek L., Gouarin S., Petitjean J., Brouard J., and Freymuth F. Human coronavirus NL63, France. Emerg. Infect. Dis. 11 8 (2005) 1225-1229
40. van der Hoek L., Pyrc K., Jebbink M.F., Vermeulen-Oost W., Berkhout R.J., Wolthers K.C., Wertheim-van Dillen P.M., Kaandorp J., Spaargaren J., and Berkhout B. Identification of a new human coronavirus. Nat. Med. 10 4 (2004) 368-373
41. van der Hoek L., Sure K., Ihorst G., Stang A., Pyrc K., Jebbink M.F., Petersen G., Forster J., Berkhout B., and Uberla K. Croup is associated with the novel coronavirus NL63. PLoS Med. 2 8 (2005) e240
42. Wong S.K., Li W., Moore M.J., Choe H., and Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J. Biol. Chem. 279 5 (2004) 3197-3201 (electronic publication 2003 Dec 11)
43. Woo P.C., Lau S.K., Tsoi H.W., Huang Y., Poon R.W., Chu C.M., Lee R.A., Luk W.K., Wong G.K., Wong B.H., Cheng V.C., Tang B.S., Wu A.K., Yung R.W., Chen H., Guan Y., Chan K.H., and Yuen K.Y. Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J. Infect. Dis. 192 11 (2005) 1898-1907
44. Xiao X., and Dimitrov D.S. The SARS-CoV S glycoprotein. Cell. Mol. Life Sci. 61 19-20 (2004) 2428-2430
45. Xiao X., Chakraborti S., Dimitrov A.S., Gramatikoff K., and Dimitrov D.S. The SARS-CoV S glycoprotein: expression and functional characterization. Biochem. Biophys. Res. Commun. 312 4 (2003) 1159-1164
46. Yeager C.L., Ashmun R.A., Williams R.K., Cardellichio C.B., Shapiro L.H., Look A.T., and Holmes K.V. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357 6377 (1992) 420-422
47. Zhong N., Ding Y., Mao Y., Wang Q., Wang G., Wang D., Cong Y., Li Q., Liu Y., Ruan L., Chen B., Du X., Yang Y., Zhang Z., Zhang X., Lin J., Zheng J., Zhu Q., Ni D., Xi X., Zeng G., Ma D., Wang C., Wang W., Wang B., Wang J., Liu D., Li X., Liu X., Chen J., Chen R., Min F., Yang P., Zhang Y., Luo H., Lang Z., Hu Y., Ni A., Cao W., Lei J., Wang S., Wang Y., Tong X., Liu W., Zhu M., Chen W., Xhen X., Lin L., Luo Y., Zhong J., Weng W., Peng S., Pan Z., Wang R., Zuo J., Liu B., Zhang N., Zhang J., Zhang B., Chen L., Zhou P., Jiang L., Chao E., Guo L., Tan X., and Pan J. Consensus for the management of severe acute respiratory syndrome. Chin. Med. J. (Engl.) 116 11 (2003) 1603-1635